US drugmaker Johnson Johnson#39;s India sales dip 3% in 2017/18

The company, currently mired in a controversy surrounding the safety of its baby talcum powder, reported overall sales of 58.28 billion rupees ($829 million) in India for the year, its filing with the country#39;s Ministry of Corporate Affairs shows.

from Moneycontrol Business News http://bit.ly/2s8z8m6